Search

everythinglearnresearchcommunity

for

Search:↓

inhibits Janus kinase enzymes to treat autoimmune conditions

Tofacitinib, also known by the brand name Xeljanz, is a medication that inhibits Janus kinase (JAK) enzymes, which play a role in the inflammatory process. It is used to treat autoimmune conditions such as rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis, and has also shown promise in treating alopecia areata, a condition that causes hair loss.

Related Terms

• Janus kinase inhibitor
• JAK inhibitor
• Rheumatoid arthritis treatment
• Psoriatic arthritis treatment
• Janus kinase inhibitors
• JAK inhibitors
• Alopecia areata treatment
• Oral Mucosa
• Oral Testosterone
• Oral JAK Inhibitors